%0 Journal Article
%T Correlation between the International Prostate Symptom Score, Ultrasound Features and Maximum Flow Rate in Cameroonian Patients with Benign Prostatic Hypertrophy
%A Landry Oriole Mbouch¨¦
%A Achille Aur¨¨le Mbassi
%A Frantz Guy Epoupa Ngall¨¨
%A Forbang Ako
%A Axel St¨¦phane Nwaha Makon
%A Boniface Moifo
%A Fru Angwafo III
%J Open Journal of Urology
%P 37-50
%@ 2160-5629
%D 2022
%I Scientific Research Publishing
%R 10.4236/oju.2022.121004
%X <strong>Background:</strong> Benign prostatic hypertrophy is the non-malignant stromal and epithelial proliferation of the prostate gland, with or without associated anatomical enlargement of the gland and clinical symptoms. Symptomatic Benign prostatic hypertrophy may cause obstructive symptoms, irritative symptoms or both obstructive symptoms include a sensation of incomplete bladder emptying, straining to void, urinary hesitancy and weak stream while irritative symptoms include dysuria, nocturia, urinary frequency and urinary urgency. A quantitative measure of the severity of lower urinary tract symptoms due to benign prostatic hypertrophy can be obtained using the International Prostate Symptoms Score. Ultrasonography is useful for helping to determine bladder and prostate size in patients with urinary lower urinary tract symptoms. Uroflowmetry is a non-invasive test that assesses voiding function. It provides valuable data on the voided volume, time is taken to reach maximum flow rate and average flow rate. The goal of this study was to improve the follow up of patients with benign prostatic hypertrophy by providing simple, available, affordable and non-invasive that best predict bladder outlet obstruction and the quality of life in these patients. <strong>Method: </strong>This was a cross-sectional analytic study carried out over a period of five months from May 2020 to September 2020 at the Yaounde Gynaeco-Obstetric and Paediatric Hospital, which is a tertiary hospital in Cameroon. Were included in the study, adult males who presented with lower urinary tract symptoms and prostatic enlargement suggestive of benign prostatic hypertrophy taking into account clinical, uroflowmetry and ultrasound findings. <strong>Results:</strong> A study population of 103 participants was recruited. The mean age of patients was 63.17 ¡À 10.26 years. Concerning the International Prostate Symptoms Score, the mean total, voiding (obstructive) and storage (irritative) scores were 14.6 ¡À 6.2, 8.5 ¡À 4.1 and 6.05 ¡À 2.7 respectively. The mean maximum flow rate was 13.44 ¡À 3.88 mL/s. The mean prostate volume was 53.71 ¡À 16.46 ml. A majority of patients have an enlarged prostate 1.5 to 2 times (46 to 60 mL) the upper limit for normal value. The intravesical prostatic protrusion was present in eighty-three (80.58%) and absent in 20 (19.42%). Above a prostate volume of 60 mL, 91% to 100% of our patients had intravesical prostatic protrusion. There was strong evidence (p &lt; 0.001) that a change from no intravesical prostatic protrusion to intravesical prostatic protrusion
%K Benign Prostate Hypertrophy
%K Intravesical Prostatic Protrusion
%K Acute Urinary Retention
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=114612